World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
17121
World Ranking
5135
National Ranking
335

Naoya Fujita publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Naoya Fujita sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 179 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Naoya Fujita D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Naoya Fujita sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Naoya Fujita is affiliated with the Japanese Foundation For Cancer Research in Japan. Their research primarily addresses key areas within medicine and biochemistry, genetics, and molecular biology, focusing on oncology, molecular biology, pulmonary and respiratory medicine, immunology, and biomedical engineering.

Their scholarly contributions include an emphasis on lung cancer treatments and mutations, lung cancer research studies, cancer cells and metastasis, 3D printing in biomedical research, cancer research and treatments, the complement system in diseases, and PI3K/AKT/mTOR signaling in cancer.

Some recent publications by Naoya Fujita include:

  • Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1, 2020, Proceedings of the National Academy of Sciences
  • Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer, 2021, Nature Communications
  • The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab, 2020, Pediatric Nephrology
  • Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms, 2020, Cancer Science
  • Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation, 2021, JCI Insight

Frequent co-authors collaborating with Naoya Fujita include Ryohei Katayama, Makoto Nishio, Noriko Yanagitani, Satoshi Takagi, and Ken Uchibori.

Their work has been published repeatedly in several scientific venues, including:

  • Cancer Science
  • npj Precision Oncology
  • Cancer Research
  • Pediatric Nephrology
  • Oncogene

Best Publications

  • Modulation of Akt kinase activity by binding to Hsp90

    Saori Sato;Naoya Fujita;Takashi Tsuruo

  • The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

    Luc Friboulet;Nanxin Li;Ryohei Katayama;Christian C. Lee

  • Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

    Takashi Tsuruo;Mikihiko Naito;Akihiro Tomida;Naoya Fujita

  • Domain Mapping Studies Reveal That the M Domain of hsp90 Serves as a Molecular Scaffold to Regulate Akt-Dependent Phosphorylation of Endothelial Nitric Oxide Synthase and NO Release

    Jason Fontana;David Fulton;Yan Chen;Todd A. Fairchild

  • Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow

    Mika Shimonaka;Mika Shimonaka;Koko Katagiri;Toshinori Nakayama;Naoya Fujita

  • Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

    Naoya Fujita;Saori Sato;Kazuhiro Katayama;Takashi Tsuruo;Takashi Tsuruo

  • Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

    Ken Uchibori;Naohiko Inase;Mitsugu Araki;Mayumi Kamada

  • Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels

    Daisuke Morishita;Ryohei Katayama;Kazuhisa Sekimizu;Takashi Tsuruo

  • Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors

    Yukinari Kato;Naoya Fujita;Akiko Kunita;Shigeo Sato

  • Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis.

    Yongke Zhang;Naoya Fujita;Takashi Tsuruo;Takashi Tsuruo

  • Two novel ALK mutations mediate acquired resistance to the next generation ALK inhibitor alectinib

    Ryohei Katayama;Luc Friboulet;Sumie Koike;Elizabeth L. Lockerman

  • Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis.

    Tetsuo Mashima;Mikihiko Naito;Naoya Fujita;Kohji Noguchi

  • Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)

    Saori Sato;Naoya Fujita;Takashi Tsuruo;Takashi Tsuruo

  • Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1.

    Naoya Fujita;Saori Sato;Atsushi Ishida;Takashi Tsuruo;Takashi Tsuruo

  • Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma

    Yukinari Kato;Mika Kaneko;Mika Kaneko;Makoto Sata;Naoya Fujita

  • Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization

    Naoya Fujita;Saori Sato;Takashi Tsuruo;Takashi Tsuruo

  • Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

    Satoshi Takagi;Shigeo Sato;Tomoko Oh-hara;Miho Takami

  • Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition

    Ryohei Katayama;Aki Aoyama;Takao Yamori;Jie Qi

  • Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

    Ryohei Katayama;Yuka Kobayashi;Yuka Kobayashi;Luc Friboulet;Elizabeth L. Lockerman

  • Binding and Phosphorylation of Par-4 by Akt Is Essential for Cancer Cell Survival

    Anindya Goswami;Ravshan Burikhanov;Aurelie de Thonel;Naoya Fujita

Frequent Co-Authors

Takashi Tsuruo
Takashi Tsuruo Japanese Foundation For Cancer Research
Takashi Tsuruo
Takashi Tsuruo Japanese Foundation For Cancer Research
Yukinari Kato
Yukinari Kato Tohoku University
Mikihiko Naito
Mikihiko Naito University of Tokyo
Alice T. Shaw
Alice T. Shaw Harvard University
Jeffrey A. Engelman
Jeffrey A. Engelman Novartis Institutes for BioMedical Research (NIBR)
Hiroyuki Arai
Hiroyuki Arai University of Tokyo
Jean-François Beaulieu
Jean-François Beaulieu Université de Sherbrooke
Yoshikazu Sugimoto
Yoshikazu Sugimoto Keio University
Justin F. Gainor
Justin F. Gainor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Naoya Fujita

Trending Scientists

Recently Published Articles